Curaleaf Opens Medical Cannabis Dispensary In Oxford To Service Central Massachusetts

Curaleaf medical marijuana dispensary

MASSACHUSETTS: Curaleaf, a provider of high-quality, reliable, and safe cannabinoid-based products, officially opened its second medical cannabis dispensary in Massachusetts. Now patients in central Massachusetts can more easily access needed medical care. This new location in Oxford joins the company’s successful Hanover dispensary that opened in fall of 2017. Located at 425 Main Street, Curaleaf offers a Read the full article…

Study: Cannabinoid Therapy Improves Dystonia In HD Patients

"Treatment with cannabinoids in all cases lead to an improvement of motor symptoms, mainly driven by improvement of dystonia," authors concluded. Patients generally reported "no relevant side effects."

GERMANY: Cannabinoid treatment is associated with improvements in dystonia in patients with early-onset Huntington’s disease, according to observational data published online ahead of print in the Journal of Huntington’s Disease. A team of investigators from Germany and Austria assessed the treatment of various synthetic or organic cannabinoid preparations – including Sativex, dronabinol, and nabilone - in seven HD patients who had been Read the full article…

Puerto Rican Alzheimer’s Patients To Be First In U.S. To Obtain Cannabis-Based Relief

indoor grow

MARYLAND: Alzheimer’s patients in Puerto Rico will be the first in the United States to obtain Hyalolex, IGC’s proprietary cannabinoid based formulation aimed at relieving many of the symptoms of Alzheimer’s Disease, such as agitation, anxiety, sleep disorder, as well as caregiver distress, among others. Pursuant to an agreement between IGC and DaMa Pharmaceutical and its Read the full article…

Review: Adjunctive Use Of Cannabinoids Efficacious In Patients With Treatment-Resistant Epilepsy

there was qualitative evidence that cannabinoids reduced seizure frequency in some patients, improved other aspects of the patients' quality of life and were generally well tolerated with mild-to-moderate AEs (adverse events)

AUSTRALIA: The adjunctive use of cannabinoids, particularly CBD (cannabidiol), typically reduces seizure frequency and improves the quality of life in patients with intractable forms of epilepsy, according to a review of clinical data published in the Journal ofNeurology, Neurosurgery & Psychiatry. Australian researchers reviewed data from six randomized, placebo-controlled studies, involving 555 patients, and from another 30 observational trials, Read the full article…

Inside Science: Marijuana May Help Solve Skin Rash Sting

“The fact that it’s illegal at the federal level, but legal at the state level -- it leads to a lot of complications in trying to do research on marijuana and its derivatives, all of the cannabinoids. They’ve overcome many years of regulatory hurdles in order to come into works, like that Parkinson’s trial that I mentioned. That is actually a trial that is going on. It’s randomized, it’s controlled, it’s the highest standards of evidence to eliminate bias,” concluded Dellavalle.

WASHINGTON: In a new video for Inside Science News Service, executive producer Karin Heineman interviews Robert Dellavalle from the University of Colorado School of Medicine, who explains how some compounds found in marijuana might help stop itching and pain in people suffering from skin diseases like eczema and psoriasis. Eczema affects millions of people, causing an itchy, painful rash. There are Read the full article…

Future Farm Signs Dispensary Lease for High Traffic Puerto Rico Location

Future Farms Signs Dispensary Deal for Puerto Rico

CANADA: Future Farm Technologies Inc., which has built a portfolio of projects across the United States and the Commonwealth of Puerto Rico, announced that its Puerto Rico subsidiary has signed the first of five planned leases for its Clinica Verde branded Puerto Ricodispensaries. The Company expects to sign two more leases in the next thirty days with the additional two leases Read the full article…

Clinical Trial: Use Of Herbal Cannabis Safe And Effective In Cancer Patients

"We cannot underestimate the role of physicians in making sure that patients can access medical marijuana," Secretary Murphy said.

ISRAEL: Cannabis administration is associated with the subjective improvement of symptoms in patients with cancer, according to clinical data published in the European Journal of Internal Medicine. Israeli researchers assessed the safety and efficacy of cannabis in a cohort of over 1,200 cancer patients over a period of six months. Ninety-six percent of patients “reported an improvement in their Read the full article…

New Study: Cannabis: Safe & Effective Medical Treatment

Questions about mmj

NEW YORK: For the first time, a major scientific study has confirmed what cannabis advocates have known for decades: that cannabis can be a safe and effective palliative treatment in patients suffering from the debilitating effects of cancer. The article, “Prospective Analysis Of Safety And Efficacy Of Medical Cannabis In Large Unselected Population Of Patients With Read the full article…

North Dakota Awards Medical Marijuana Seed-to-Sale Tracking Contract To BioTrackTHC

The voter-initiated measure, organized by the grass-roots group Legalize North Dakota, legalizes the possession, use, and sale of cannabis, as well as the possession of marijuana paraphernalia, by those over the age of 21 and also expunges past marijuana convictions.

NORTH DAKOTA: The North Dakota Department of Health, the government agency responsible for implementing the state’s voter-approved medical marijuana program, has awarded the contract to BioTrackTHC to develop and implement the state’s medical marijuana seed-to-sale traceability system.  The system will allow designated regulatory officials to enforce compliance across the state’s marijuana seed-to-sale supply chain, providing Read the full article…

Medical Benefits In Legal Cannabis Products

cannabis has many medical benefits

CALIFORNIA: The U.S. medical cannabis market was valued at USD 5.44 billion in 2016 and is expected to be valued at USD 19.48 billion by 2024, According to a report by Hexa Research. The expected growth is driven by the growing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain. Symptoms Read the full article…